Stephanie Rush Selected Research

Stephanie Rush Research Topics

4	COVID-19 10/2022 - 01/2021
2	Infections 01/2022 - 01/2021
2	Rheumatoid Arthritis 01/2021 - 11/2003
2	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2020
2	Necrosis 01/2021 - 01/2020
1	Wounds and Injuries (Trauma) 05/2024
1	Melanoma (Melanoma, Malignant) 02/2023
1	Hypophysitis 02/2023
1	Disease Progression 10/2022
1	Breakthrough Infections 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Lupus Nephritis 01/2020

2	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 05/2024 - 01/2020
1	Immune Checkpoint InhibitorsIBA 02/2023
1	cyclopropapyrroloindoleIBA 02/2023
1	Monoclonal AntibodiesIBA 10/2022
1	VaccinesIBA 01/2022
1	Immunomodulating AgentsIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	Tumor Necrosis Factor InhibitorsIBA 10/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	GlucocorticoidsIBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	Etanercept (Enbrel)FDA Link 11/2003

1	Therapeutics 02/2023